| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |